Publications by authors named "Paul De Lay"

Claim this Profile
M
Modeling the epidemiological impact of the UNAIDS 2025 targets to end AIDS as a public health threat by 2030.
John Stover, Robert Glaubius, Yu Teng, Sherrie Kelly, Tim Brown, Paul R De Lay

PLoS Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ending AIDS as a public health threat by 2030: Time to reset targets for 2025.
Paul R De Lay, Adèle Benzaken, Quarraisha Abdool Karim, Sani Aliyu, Carolyn Amole, Michaela Clayton

PLoS Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: What Is Required to End the AIDS Epidemic as a Public Health Threat by 2030? The Cost and Impact of the Fast-Track Approach.
John Stover, Lori Bollinger, Jose Antonio Izazola, Luiz Loures, Paul DeLay

PLoS One· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What Is Required to End the AIDS Epidemic as a Public Health Threat by 2030? The Cost and Impact of the Fast-Track Approach.
John Stover, Lori Bollinger, Jose Antonio Izazola, Luiz Loures, Paul DeLay

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protecting the confidentiality and security of personal health information in low- and middle-income countries in the era of SDGs and Big Data.
Eduard J Beck, Wayne Gill, Paul R De Lay

Glob Health Action· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: What Is Required to End the AIDS Epidemic as a Public Health Threat by 2030? The Cost and Impact of the Fast-Track Approach.
John Stover, Lori Bollinger, Jose Antonio Izazola, Luiz Loures, Paul DeLay

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scaling-up the use of generic antiretrovirals in resource-limited countries: generic drugs for health.
Eduard J Beck, Carlos Passarelli, Iris Lui, Anne-Claire Guichard, Mariangela Simao, Paul De Lay

Antivir Ther· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of Option B+ for HIV prevention and treatment of mothers and children in Malawi.
Olufunke Fasawe, Carlos Avila, Nathan Shaffer, Erik Schouten, Frank Chimbwandira, Paul De Lay

PLoS One· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of government HIV/AIDS financing: a 10-year trend analysis from 125 low- and middle-income countries.
Carlos Ávila, Dejan Loncar, Peter Amico, Paul De Lay

BMC Public Health· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costs and cost-effectiveness of HIV community services: quantity and quality of studies published 1986-2011.
Eduard J Beck, Olufunke Fasawe, Patricia Ongpin, Peter Ghys, Carlos Avilla, Paul De Lay

Expert Rev Pharmacoecon Outcomes Res· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Counting the cost of not costing HIV health facilities accurately: pay now, or pay more later.
Eduard J Beck, Carlos Avila, Sofia Gerbase, Guy Harling, Paul De Lay

Pharmacoeconomics· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pattern and levels of spending allocated to HIV prevention programs in low- and middle-income countries.
Peter Amico, Benjamin Gobet, Carlos Avila-Figueroa, Christian Aran, Paul De Lay

BMC Public Health· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cost of treatment and care for people living with HIV infection: implications of published studies, 1999-2008.
Eduard J Beck, Guy Harling, Sofia Gerbase, Paul DeLay

Curr Opin HIV AIDS· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Financing the response to HIV in low-income and middle-income countries.
José Antonio Izazola-Licea, Jan Wiegelmann, Christian Arán, Teresa Guthrie, Paul De Lay

J Acquir Immune Defic Syndr· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are we on course for reporting on the Millennium Development Goals in 2015?
Deborah Rugg, Hein Marais, Michel Carael, Paul De Lay, Matthew Warner-Smith

J Acquir Immune Defic Syndr· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tailoring AIDS prevention.
Paul R De Lay

Science· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV/AIDS estimates and the quest for universal access.
Kevin M De Cock, Paul De Lay

Lancet· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Writing on the wall for UNAIDS: UNAIDS replies.
Paul De Lay

BMJ· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are we spending too much on HIV?
Paul de Lay, Robert Greener, Jose Antonio Izazola

BMJ· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries.
John Stover, Stefano Bertozzi, Juan-Pablo Gutierrez, Neff Walker, Karen A Stanecki, Paul De Lay

Science· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender and monitoring the response to HIV / AIDS pandemic.
Paul DeLay

Emerg Infect Dis· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Politics of monitoring and evaluation: Lessons from the AIDS epidemic.
Paul De Lay, Valerie Manda

New Dir Eval· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis